These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26090082)

  • 21. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E; Ligori LD
    J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The perception of apathy by caregivers of patients with dementia in Parkinson's disease.
    Camargo CHF; Serpa RA; Matnei T; Sabatini JS; Teive HAG
    Dement Neuropsychol; 2016; 10(4):339-343. PubMed ID: 29213479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS).
    Matsuzono K; Sato K; Kono S; Hishikawa N; Ohta Y; Yamashita T; Deguchi K; Nakano Y; Abe K
    J Alzheimers Dis; 2015; 48(3):757-63. PubMed ID: 26402119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study.
    Mamikonyan E; Xie SX; Melvin E; Weintraub D
    Mov Disord; 2015 Jun; 30(7):912-8. PubMed ID: 25914281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychiatric co-morbidities in non-demented Parkinson's disease.
    Rai NK; Goyal V; Kumar N; Shukla G; Srivastava AK; Singh S; Behari M
    Ann Indian Acad Neurol; 2015; 18(1):33-8. PubMed ID: 25745308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Emelin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):25-33. PubMed ID: 18427456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rivastigmine (Exelon) for dementia in patients with Parkinson's disease.
    Giladi N; Shabtai H; Gurevich T; Benbunan B; Anca M; Korczyn AD
    Acta Neurol Scand; 2003 Nov; 108(5):368-73. PubMed ID: 14616309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of characteristics affecting instrumental activities of daily living in Parkinson's disease patients without dementia.
    Choi SM; Yoon GJ; Jung HJ; Kim BC
    Neurol Sci; 2019 Jul; 40(7):1403-1408. PubMed ID: 30931509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric symptoms in Parkinson's disease dementia are associated with increased caregiver burden.
    Oh YS; Lee JE; Lee PH; Kim JS
    J Mov Disord; 2015 Jan; 8(1):26-32. PubMed ID: 25614783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of N-methyl-D-aspartate receptor glycine site temporally ameliorates neuropsychiatric symptoms of Parkinson's disease with dementia.
    Tsai CH; Huang HC; Liu BL; Li CI; Lu MK; Chen X; Tsai MC; Yang YW; Lane HY
    Psychiatry Clin Neurosci; 2014 Sep; 68(9):692-700. PubMed ID: 24612097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
    Bullock R; Cameron A
    Curr Med Res Opin; 2002; 18(5):258-64. PubMed ID: 12240787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease.
    D'Onofrio G; Sancarlo D; Addante F; Ciccone F; Cascavilla L; Paris F; Elia AC; Nuzzaci C; Picoco M; Greco A; Panza F; Pilotto A
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):965-75. PubMed ID: 25504466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
    Rösler M
    Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of rivastigmine in patients with Parkinson's disease dementia.
    Willan AR; Goeree R; Pullenayegum EM; McBurney C; Blackhouse G
    Pharmacoeconomics; 2006; 24(1):93-106. PubMed ID: 16445306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.